Skip to main content
Clinical Trials

A021202 Prospective Randomized Phase II Trial Of Pazopanib (NSC #737754, IND #75648) Versus Placebo In Patients With Progressive Carcinoid Tumors (CTRC #14-0046)

ClinicalTrials.gov Identifier

NCT01841736

Learn more
clinicaltrials.gov

About This Study

This randomized phase II trial studies how well pazopanib hydrochloride works in treating patients with carcinoid tumors that are growing, spreading, or getting worse. Pazopanib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth.